Jared Rochelle
Pain Medicine · Hammond, LANPI 1689998601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $683 and has fallen 92.3% since, to $53 in 2025. That places this record below the midpoint for pain medicine clinicians in LA, where the typical reported total is $3,650.
Across 47 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$127
- UCB, Inc.$125
- Stryker$101
- Boston Scientific$63
- Zyla Life Sciences, Inc.$45
- Tersera Therapeutics LLC$44
- plus $338 from 16 others
What the payments were for
- Speaking & faculty fees$283%
- Food & beverage$81697%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 7 | $127 |
| UCB, Inc. | 10 | $125 |
| Stryker | 3 | $101 |
| Boston Scientific | 2 | $63 |
| Zyla Life Sciences, Inc. | 3 | $45 |
| Tersera Therapeutics LLC | 2 | $44 |
| Promius Pharma LLC | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| Si-bone, Inc. | 2 | $30 |
| Acorda Therapeutics, Inc | 2 | $28 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Nevro Corp. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Grifols USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$844 in reported general payments places this provider in the 20th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 270 | $5,034 |
| MovantikNaloxegol Oxalate | 11 | $4,603 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 162 | $4,303 |
| Lidocaine | 36 | $3,851 |
| Gabapentin | 277 | $3,237 |
| Baclofen | 166 | $1,970 |
| Diclofenac Sodium | 116 | $1,612 |
| Methocarbamol | 137 | $1,376 |
| Duloxetine Hcl | 58 | $1,321 |
| Tramadol Hcl | 128 | $827 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $705 |
| Pregabalin | 51 | $698 |
| Tizanidine Hcl | 43 | $580 |
| Oxycodone Hcl | 42 | $442 |
| Meloxicam | 81 | $342 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Hammond
- Mohamed ElkershHammond$12K
- William ChiangHammond$6K
- Shaun KuoniHammond$3K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
- Yashar EshraghiNew Orleans$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.